Literature DB >> 20141941

Development of a real-time RT-PCR method for enumeration of viable Bifidobacterium longum cells in different morphologies.

Sebastian Reimann1, Franck Grattepanche, Enea Rezzonico, Christophe Lacroix.   

Abstract

Viability of probiotic bacteria is traditionally assessed by plate counting which has several limitations, including underestimation of cells in aggregates or chains morphology. We describe a quantitative PCR (qPCR)-based method for an accurate enumeration of viable cells of Bifidobacterium longum NCC2705 exhibiting different morphologies by measuring the mRNA levels of cysB and purB, two constitutively expressed housekeeping genes. Three primer-sets targeting short fragments of 57-bp of cysS and purB and one 400-bp fragment of purB were used. Cell quantification of serially diluted samples showed a good correlation coefficient of R(2) 0.984 +/- 0.003 between plate counts and qRT-PCR for all tested primer sets. Loss of viable cells exposed to a lethal heat stress (56 degrees C, 10, 20 and 30 min) was estimated by qRT-PCR and plate counts. No significant difference was observed using qRT-PCR targeting the 400-bp fragment of purB compared to plate counts indicating that this fragment is a suitable marker of cell viability. In contrast, the use of the 57-bp fragments led to a significant overestimation of viable cell counts (18 +/- 3 and 7 +/- 2 fold for cysB and purB, respectively). Decay of the mRNA fragments was studied by treatment of growing cells with rifampicin prior qRT-PCR. The 400-bp fragment of purB was faster degraded than the 57-bp fragments of cysB and purB. The 400-bp fragment of purB was further used to enumerate viable cells in aggregate state. Cell counts were more than 2 log(10) higher using the qRT-PCR method compared to plate counts. Growing interest in probiotic characteristics of aggregating bacteria cells make this technique a valuable tool to accurately quantify viable probiotic bacteria exhibiting heterogeneous morphology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20141941     DOI: 10.1016/j.fm.2009.10.010

Source DB:  PubMed          Journal:  Food Microbiol        ISSN: 0740-0020            Impact factor:   5.516


  6 in total

Review 1.  Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design.

Authors:  Gary P Wormser; Phillip J Baker; Susan O'Connell; Andrew R Pachner; Ira Schwartz; Eugene D Shapiro
Journal:  Vector Borne Zoonotic Dis       Date:  2012-05-23       Impact factor: 2.133

2.  Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.

Authors:  Radha Iyer; Priyanka Mukherjee; Kemeng Wang; Joshua Simons; Gary P Wormser; Ira Schwartz
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

3.  Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Susan O'Connell; Andrew R Pachner; Ira Schwartz; Eugene D Shapiro; Gerold Stanek; Franc Strle
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-18       Impact factor: 2.803

4.  Evaluation of culture media for selective enumeration of bifidobacteria and lactic acid bacteria.

Authors:  Judit Süle; Tímea Kõrösi; Attila Hucker; László Varga
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

Review 5.  Evolution of microbiological analytical methods for dairy industry needs.

Authors:  Danièle Sohier; Sonia Pavan; Armelle Riou; Jérôme Combrisson; Florence Postollec
Journal:  Front Microbiol       Date:  2014-02-07       Impact factor: 5.640

6.  Designing primers and evaluation of the efficiency of propidium monoazide - Quantitative polymerase chain reaction for counting the viable cells of Lactobacillus gasseri and Lactobacillus salivarius.

Authors:  Chieh-Hsien Lai; Sih-Rong Wu; Jen-Chieh Pang; Latha Ramireddy; Yu-Cheng Chiang; Chien-Ku Lin; Hau-Yang Tsen
Journal:  J Food Drug Anal       Date:  2016-11-29       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.